2nd World Congress on Recurrent Pregnancy Loss-WCRPL 2017
Start:
Thu, 19 Jan 2017, 08:15
End:
Sun, 22 Jan 2017, 12:10
Website:
Hashtag:
#WCRPL2017
Venue:
Exhibit
Symposia
Workshops
Organiser
Sponsor
Congress Dates
19-22 January 2017
Congress Venue
Hotel Majestic Barriere
10 Boulevard de la Croisette
06407 Cannes, France
Tel: +33 4 92 98 77 00
Website: Hotel Majestic Barriere
Who Should Attend
• Pharmacologists
• Maternal Fetal Medicine and Ultra Sound Specialists
• Imaging – 3D Specialists
• Psychiatrists
• Psychologists
• Rheumatologists
• Infertility and IVF Units
• Gynecologists
• Obstetricians
• Reproductive Endocrinologists
• Internists
• Hematologists
• Reproductive Medicine Specialists
• Reproductive Immunologists
Language
The official language of the Congress is English.
Dress Code
Business casual for all occasions.
Currency
The Euro is the official currency of France. Currency exchange can be made in most banks and post offices as well as in train stations, airports and exchange offices near major tourist sites.
Registration Fees in Euro (Per Person) Fees apply to payment received prior to the indicated Registration Deadlines. | |||
Registration Type | Early-Bird | Regular From 5 November, 2016 to 5 January, 2017 | Onsite |
Participants | 450 € | 500 € | 580 € |
Participants from Developing Countries* | 350 € | 375 € | 400 € |
Residents, Nurses, Students** | 350 € | 375 € | 400 € |
* Developing Countries; in accordance with the International Statistical Institute list of developing countries based on United Nations sources.
To view the list, please click here.
** Students must submit a student card valid for 2017
Registration fees for Congress participants include:
Participation in the Congress scientific sessions
Printed Congress materials
An invitation to the Welcome Reception
Entrance to the Exhibition
Refreshments as per times scheduled in the scientific program
Group Registration Policy:
The Group Registration procedure will be valid for a group with a minimum of 10 delegates.
A special rate of 375 € per person will be given for a group registration.
For more information on group registration please contact: [email protected]
The group rate is not applicable to participants from Developing Countries.
Thursday, 19 January 2017 | |
08:15-08:45 | Opening Ceremony & Welcome Words |
08:45-11:00 | Session I. Epidemiological Aspects, Evidence Based Medicine Chairs: Asher Bashiri (Israel) and William Kutteh (USA) |
08:45-09:30 | Recurrent Pregnancy Loss – Overview and Endocrine Aspects |
09:30-10:00 | Impact of Consecutive versus Non-Consecutive Miscarriages in RPL |
10:00-10:30 | Progress on Standardized Outcomes for RPL Studies |
10:30-1100 | The BMI and the Risks for RPL |
11:00-11:15 | Coffee Break |
11:15-13:45 | Session II. Immunology Chairs: Bettina Toth (Austria) and Ole Christiansen (Denmark) |
11:15-11:45 | Immunology in RPL: Facts and Fiction |
11:45-12:15 | HLA-DR and -DQ (2000 patients) in RPL in the Danish Population |
12:15-12:45 | Lymphocyte Immunization Therapy in Recurrent Pregnancy Loss – Is There a Place for This Treatment? |
12:45-13:15 | Immunologic Processes at the Feto-Maternal Interphase |
13:15-13:45 | Immunologic Treatment Option, Cons and Pros |
13:45-14:45 | Lunch Break / Poster / Exhibition |
14:45-17:45 | Oral Communications I: Epidemiology, Immunology, Thrombophilia and RPL Chairs: Asher Bashiri (Israel) and James Scott (USA) |
14:45 | Evaluating the Role of Vitamin D3 in Recurrent Miscarriage, a Narrative Systematic Literature Review |
14:57 | Does Ethnicity Influence Maternal and Pregnancy Characteristics in Women Experiencing Recurrent Pregnancy Loss? |
15:09 | Thrombophilia Gene Mutations in Georgian Women with Recurrent Pregnancy Loss (RPL) |
15:21 | Decidual Th1/Th2&NK1/NK2 Phenotyping with 8-color Flowcytometry in Recurrent Miscarriage |
15:33 | Clinical and Immunologic Profile of Women with Recurrent Pregnancy Losses in a Tertiary Hospital in the Philippines |
15:45 | Identification of Immunological Biomarkers for Recurrent Pregnancy Loss |
15:57 | An Immunological Profile is Associated with Development of Clinical Abnormalities in Women with Recurrent Pregnancy Loss |
16:09 | Analysis of CD138+ Uterine Plasma Cells in Patients with Recurrent Miscarriage |
16:21 | Higher Incidence of Colonization with Gardnerella Vaginalis in Patients with Recurrent Miscarriage and Elevated Peripheral Natural Killer Cells |
16:33 | Characteristics of Subsequent (Index) Pregnancy in Women Experiencing Recurrent Pregnancy Loss |
16:45 | G-CSF Treatment in Unexplained Recurrent Pregnancy Loss: Results of a Controlled Trial on 120 Women and Total Data on Ten Years Experience |
16:57 | A 9-year Retrospective Analysis of Associated Medical Conditions in a Tertiary Level Recurrent Miscarriage Clinic in Cape Town, South Africa – Is BMI the Tip of the Iceberg in RM? |
17:45-18:45 | Welcome Reception |
Friday, 20 January 2017 | |
08:00-10:30 | Session III. Infertility Chairs: Raoul Orvieto (Israel) and Eitan Lunenfeld (Israel) |
08:00-08:30 | The Continuing Spectrum of Infertility and RPL |
08:30-09:00 | Recurrent Implantation Failure |
09:00-09:30 | The Role of Oxidative Stress and Anti-Oxidants Treatment in (Unexplained?) RPL |
09:30-10:00 | Metformin – Old News? Does Metformin Prevent Miscarriages in PCOS Patients? |
10:00-10:30 | To select or Not to Select – The Role of Sperm Selection Techniques in RPL Prevention |
10:30-11:00 | Coffee Break / Posters / Exhibition |
11:00-13:30 | Session IV. Anatomy Chairs: Mala Arora (India) and Olivier Toullalan (France) |
11:00-11:30 | Anatomical Causes of RPL, the Role of 3D Ultrasound and the Significance of Determining Fetal Abnormalities |
11:30-12:00 | Endoscopic Septectomy for RPL Patients |
12:00-12:30 | Late Pregnancy Loss |
12:30-13:00 | The Role of Hystero-Embryoscopy in the Management of RPL |
13:00-13:30 | Cervical Incompetence Evaluation and Management |
13:30-14:30 | Lunch Break / Posters / Exhibition |
14:30-15:00 | Industry Supported Session |
15:00-17:00 | Session V. Thrombophilia Chairs: Avraham Harlev (Israel) and Alric Mondragon (Philippines) |
15:00-15:30 | Guidelines for Evaluation Hereditary Thrombophilia among Patients with Recurrent Pregnancy Loss and New Diagnostic Test |
15:30-16:00 | APLA Syndrome and RPL |
16:00-16:30 | Treatment Options in Refractory Obstetric Antiphospholipid Syndrome |
16:30-17:00 | Is Aspirin a Treatment for RPL? |
Saturday, 21 January 2017 | |
08:00-10:30 | Session VI. Genetics Chairs: Elias Dahdouh (Canada) and Vasilios Tanos (Cyprus) |
08:00-08:30 | Genetic Factors in Recurrent Pregnancy Loss |
08:30-09:00 | Molecular Analysis of Chromosomal Abnormalities in Products of Conception (POCs) |
09:00-09:30 | Embryoscopy in Unexplained Recurrent Spontaneous Abortions Correlation of Embryo Morphology and Karyotype |
09:30-10:00 | PGD/PGS in RPL: Is It Really Beneficial? |
10:00-10:30 | Case Presentations and Panel Discussion All session speakers |
10:30-11:00 | Coffee Break / Posters / Exhibition |
11:00-12:30 | Session VII. Psychological and Organizational Support Chairs: Bruce Young (USA) and Arsen Gvenetadze (Georgia) |
11:00-11:30 | Pregnancy Loss Prevention Center: Clinical Experience |
11:30-12:00 | Learning to stay with what is: Mindfulness training as a way to enhance stress management, acceptance and compassion due to recurrent pregnancy loss. |
12:00-12:30 | How to Organize an RPL Clinic |
12:30-13:30 | Lunch Break / Posters/ Exhibition |
13:30-16:00 | Oral Communications II: Anatomy, Genetics and Fertility Chairs: William Kutteh (USA) and Elias Dahdouh (Canada) |
13:30 | Pregnancy Outcomes in Women with Recurrent Miscarriages Following Endometrial Biopsy- a Systematic Review of Literature |
13:42 | Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) does not Improve Miscarriage Rate for Patients with Recurrent Implantation Failure and/or Male Factor Infertility |
13:54 | The Value of Three-dimensional Ultrasound in Diagnosis of Congenital Uterine Anomalies |
14:06 | Anti-P Allo-Antibodies as a Cause for Recurrent Early Miscarriages & Late Pregnancy Loss |
14:18 | The Genome-Wide Association Study Identifying TSHR and C1d as New Susceptibility Loci for Obstetric Antiphospholipid Syndrome |
14:30 | Recurrent Pregnancy Loss and Antiphospholipde Syndrome |
14:42 | Unraveling the Diverse Landscape of Genomic Abnormalities from Conception to Childhood |
14:54 | Balanced Structural Chromosomal Anomalies in Couples with Recurrent Pregnancy Loss (RPL) |
15:06 | A Meta-analysis of Low-Molecular Weight Heparin to Prevent Pregnancy Loss in Women with Inherited Thrombophilia |
15:18 | The Contribution of Fertility Treatments to Pregnancy Outcome in Patients with Recurrent Pregnancy Loss |
15:30 | Deficiency of Placental Copy Number Variations in Recurrent Pregnancy Loss Patients |
15:42 | Application of Thrombelastography to Monitor The Change of Coagulation Function in Patients of Recurrent Spontaneous Abortion with Different Times Miscarriages Before and After Pregnancy |
16:00-16:15 | Short Break |
16:15-18:15 | Stop, Sit, Breath, Let It Be – Experiential Workshop in Mindfulness |
Sunday, 22 January 2017 | |
08:00-10:00 | Meet the Expert Session Interactive session with the audience, case presentations Moderator: Asher Bashiri (Israel) Arsen Gvenetadze (Georgia), Avraham Harlev (Israel), Alric Mondragon(Philippines), James Scott (USA), Vasilis Tanos (Cyprus), Bruce Young (USA) |
10:00-12:00 | Oral Communications III: Different Aspects of RPL Chairs: Bruce Young (USA) and Avraham Harlev (Israel) |
10:00 | Prevalence of Vitamin D Levels in the Recurrent Pregnancy Loss Population |
10:12 | Mechanisms of Action of G-CSF Treatment in Recurrent Pregnancy Loss: Immunological and Trophoblast Growth Pathways |
10:24 | Evil Eye, Stress and Overwork: Theories of Miscarriage Causations among Qatari Women |
10:36 | Pregnancy Outcomes in the Recurrent Miscarriage Clinic – Is One Scan Sufficient? |
10:48 | A New Exclusive Innovation Model of Obstetrical Pessary – Prevention and Treatment of Cervical Insufficiency and Habitual Abortion |
11:00 | Tendencies of Depression and Anxiety are Highly Prevalent among Women with Recurrent Pregnancy Loss and Infertility |
11:12 | RNA-Seq Analysis of Chorionic Villi from Recurrent Pregnancy Loss Cases Compared to Normal Early Pregnancy |
11:24 | Low Molecular Weight Heparin (LMWH): Enoxaparin as Adyuvant of in Vitro Fertilization Techniques (IVF) in Women with Recurrent Implantation Failures (RIF): Obstetric and Perinatal Outcome: Preliminary Report |
12:00-12:10 | Closing Remarks |
More events
Wed, 16 Oct 2024 - Sat, 19 Oct 2024
Wed, 16 Oct 2024 - Fri, 18 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024
Thu, 17 Oct 2024 - Sun, 20 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024
Thu, 17 Oct 2024 - Sat, 19 Oct 2024